Track aleniglipron in Peptimes™
Aleniglipron (GSBR-1290) is an investigational small-molecule drug, not a peptide, taken by mouth in its trials. FDA's substance registry also lists an L-arginine salt. (Source: FDA's substance registry (GSRS).)
Is aleniglipron FDA-approved?
No. Aleniglipron is investigational: it's being studied in clinical trials and isn't FDA-approved for any use.
Aleniglipron
Also: GSBR-1290, GSBR-1001290, aleniglipron L-arginine
- Status label in the Peptimes Library
- Phase 3 Trials
- Routes in Peptimes
- Oral
- Updated
- 1 Nov 2026
US regulatory status
FDA status
Not FDA-approved for any use. Drugs@FDA lists no application with aleniglipron as an active ingredient.
Source: Drugs@FDA, checked 1 Nov 2026
Investigational
Yes.
Source: ClinicalTrials.gov, checked 1 Nov 2026
How to track it in Peptimes
Add aleniglipron in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Phase 3 Trials”, which describes its investigational status. It isn’t an approval.
- Logging: the amount you took and how you feel.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell aleniglipron or any other compound.
More sources
- NIH, ClinicalTrials.gov, NCT07654361, checked 1 Nov 2026: a Phase 3 study of aleniglipron sponsored by Gasherbrum Bio, a subsidiary of Structure Therapeutics, recruiting.
- NIH, ClinicalTrials.gov, studies of aleniglipron, checked 1 Nov 2026: registered studies, including Phase 3 studies, given by mouth.
- FDA, Drugs@FDA, searched 1 Nov 2026: no application lists aleniglipron as an active ingredient.
- FDA, Global Substance Registration System, Aleniglipron, checked 1 Nov 2026: a chemical (small-molecule) substance, the codes GSBR-1290 and GSBR-1001290, and the L-arginine salt.